Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Megapro Biomedical Co. Ltd.

Clinical trials sponsored by Megapro Biomedical Co. Ltd., explained in plain language.

MegaPro Biomedical Co. Ltd. 6827 TPEx

Taiwanese biomedical company developing drug delivery and medical devices.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1

New daily pill MPB-1734 enters human trials for Hard-to-Treat cancers

Disease control Recruiting now

This early-phase trial is testing a new oral drug called MPB-1734 in adults with advanced solid tumors that have not responded to standard treatments. The study has two parts: first, finding the safest dose, and second, testing that dose in specific tumor types. Researchers will …

Phase: PHASE1, PHASE2 • Sponsor: MegaPro Biomedical Co. Ltd. • Aim: Disease control

Last updated Jun 27, 2026 07:56 UTC